ZBH
69
15
ILMN
31
4
DOV
48
2
HCA
37
7
JCI
44
7
AAPL
64
3
STX
34
2
LH
33
3
PBI
30
-8
HOG
29
4
TXN
29
4
CTAS
36
8
JWN
72
9
XRX
48
2
T
32
2
LB
16
9
GE
60
5
IVZ
42
13
HRB
40
3
BLK
47
3
ZBH
69
15
ILMN
31
4
DOV
48
2
HCA
37
7
JCI
44
7
AAPL
64
3
STX
34
2
LH
33
3
PBI
30
-8
HOG
29
4
TXN
29
4
CTAS
36
8
JWN
72
9
XRX
48
2
T
32
2
LB
16
9
GE
60
5
IVZ
42
13
HRB
40
3
BLK
47
3
Financhill
Back

Catalyst Pharmaceuticals 10K Form

Buy
55

CPRX
Catalyst Pharmaceuticals

Last Price:
$21.26
Seasonality Move:
6.88%

7 Day Trial

ALL ACCESS PASS

$ 7

Key Filings

10K form not available

Receive CPRX News And Ratings

See the #1 stock for the next 7 days that we like better than CPRX

CPRX Financial Statistics

Sales & Book Value

Annual Sales: $398.2M
Cash Flow: $72.6M
Price / Cash Flow: 11.68
Annual Sales: $5.54
Price / Book: 3.84

Profitability

EPS (TTM): 1.18000
Net Income (TTM): $142.8M
Gross Margin: $346.2M
Return on Equity: 27.81%
Return on Assets: 23.73%

Catalyst Pharmaceuticals Earnings Forecast

Key Catalyst Pharmaceuticals Financial Ratios

  • The Gross Profit Margin over the past 22 years for CPRX is 86.95%.
  • The Selling, General & Administrative Expenses for CPRX have been equal to 33.58% of Gross Profit Margin.
  • The Research & Development expenses have been 23.39% of Revenue.
  • The Interest Expense is 0.00% of Operating Income.
  • Per Share Earnings over the last 22 years have been positive in 10 years.

Catalyst Pharmaceuticals Stock Price Chart

Industry, Sector and Symbol

Stock Exchange: NASDAQ
Industry: Biotechnology
Sector: Health Care
Current Symbol: CPRX
CUSIP: 14888U
Website: catalystpharma.com

Debt

Debt-to-Equity Ratio: 0
Current Ratio: 5.11
Quick Ratio: 4.75

Price-to-Earnings

Trailing P/E Ratio: 33.76
Forward P/E Ratio: 10.16

CPRX Technical Analysis vs Fundamental Analysis

Buy
55
Catalyst Pharmaceuticals (CPRX) is a Buy

Is Catalyst Pharmaceuticals a Buy or a Sell?